AAAAAA

   
Results: 1-11 |
Results: 11
CHIMERIC INTERLEUKIN-2 RECEPTORS FOR THE ACTIVATION OF LYMPHOCYTES
Authors: TEITZ S WAKS T SCHINDLER D ESHHAR Z
Citation: S. Teitz et al., CHIMERIC INTERLEUKIN-2 RECEPTORS FOR THE ACTIVATION OF LYMPHOCYTES, European cytokine network, 9(3), 1998, pp. 510-510
HARNESSING SYK FAMILY TYROSINE KINASES AS SIGNALING DOMAINS FOR CHIMERIC SINGLE-CHAIN OF THE VARIABLE DOMAIN RECEPTORS - OPTIMAL-DESIGN FORT-CELL ACTIVATION
Authors: FITZERATTAS CJ SCHINDLER DG WAKS T ESHHAR Z
Citation: Cj. Fitzerattas et al., HARNESSING SYK FAMILY TYROSINE KINASES AS SIGNALING DOMAINS FOR CHIMERIC SINGLE-CHAIN OF THE VARIABLE DOMAIN RECEPTORS - OPTIMAL-DESIGN FORT-CELL ACTIVATION, The Journal of immunology, 160(1), 1998, pp. 145-154
COMBINING THE INTRACELLULAR TYROSINE KINASE SYK WITH EXTRACELLULAR SCFV FOR T-CELL ACTIVATION
Authors: FITZERATTAS CJ SCHINDLER DG WAKS T ESHHAR Z
Citation: Cj. Fitzerattas et al., COMBINING THE INTRACELLULAR TYROSINE KINASE SYK WITH EXTRACELLULAR SCFV FOR T-CELL ACTIVATION, Journal of allergy and clinical immunology, 99(1), 1997, pp. 170-170
DIRECT T-CELL ACTIVATION BY CHIMERIC SINGLE-CHAIN FV-SYK PROMOTES SYK-CBL ASSOCIATION AND CBL PHOSPHORYLATION
Authors: FITZERATTAS CJ SCHINDLER DG WAKS T ESHHAR Z
Citation: Cj. Fitzerattas et al., DIRECT T-CELL ACTIVATION BY CHIMERIC SINGLE-CHAIN FV-SYK PROMOTES SYK-CBL ASSOCIATION AND CBL PHOSPHORYLATION, The Journal of biological chemistry, 272(13), 1997, pp. 8551-8557
REDIRECTING EFFECTOR LYMPHOCYTES USING CHIMERIC RECEPTORS WITH ANTIBODY SPECIFICITY - NEW APPROACH FOR IMMUNO-GENE THERAPY OF CANCER
Authors: ESHHAR Z WAKS T GROSS G LUSTGARTEN J BACH N FITZERATTAS CJ RATNER A SCHINDLER DG
Citation: Z. Eshhar et al., REDIRECTING EFFECTOR LYMPHOCYTES USING CHIMERIC RECEPTORS WITH ANTIBODY SPECIFICITY - NEW APPROACH FOR IMMUNO-GENE THERAPY OF CANCER, Journal of clinical biochemistry and nutrition, 21(1), 1996, pp. 86-87
THE T-BODY APPROACH - POTENTIAL FOR CANCER-IMMUNOTHERAPY
Authors: ESHHAR Z BACH N FITZERATTAS CJ GROSS G LUSTGARTEN J WAKS T SCHINDLER DG
Citation: Z. Eshhar et al., THE T-BODY APPROACH - POTENTIAL FOR CANCER-IMMUNOTHERAPY, Perspectives in mathematical logic, 18(2), 1996, pp. 199-209
PROLONGED INHIBITION OF IGE PRODUCTION IN MICE FOLLOWING TREATMENT WITH AN IGE-SPECIFIC IMMUNOTOXIN
Authors: LUSTGARTEN J WAKS T ESHHAR Z
Citation: J. Lustgarten et al., PROLONGED INHIBITION OF IGE PRODUCTION IN MICE FOLLOWING TREATMENT WITH AN IGE-SPECIFIC IMMUNOTOXIN, Molecular immunology, 33(3), 1996, pp. 245-251
TARGETING T-CELLS TO CANCER USING CHIMERIC RECEPTORS
Authors: ESHHAR Z WAKS T FITZERATTAS CJ FEIGELSON S TEITZ S SCHINDLER DG
Citation: Z. Eshhar et al., TARGETING T-CELLS TO CANCER USING CHIMERIC RECEPTORS, Immunology, 89, 1996, pp. 114-114
CHIMERIC T-CELL RECEPTORS SPECIFIC TO A B-LYMPHOMA IDIOTYPE - A MODELFOR TUMOR-IMMUNOTHERAPY
Authors: GROSS G LEVY S LEVY R WAKS T ESHHAR Z
Citation: G. Gross et al., CHIMERIC T-CELL RECEPTORS SPECIFIC TO A B-LYMPHOMA IDIOTYPE - A MODELFOR TUMOR-IMMUNOTHERAPY, Biochemical Society transactions, 23(4), 1995, pp. 1079-1082
TARGETING OF T-LYMPHOCYTES TO NEU HER2-EXPRESSING CELLS USING CHIMERIC SINGLE-CHAIN FV RECEPTORS/
Authors: STANCOVSKI I SCHINDLER DG WAKS T YARDEN Y SELA M ESHHAR Z
Citation: I. Stancovski et al., TARGETING OF T-LYMPHOCYTES TO NEU HER2-EXPRESSING CELLS USING CHIMERIC SINGLE-CHAIN FV RECEPTORS/, The Journal of immunology, 151(11), 1993, pp. 6577-6582
ANTILEUKOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 ANTIBODIES INHIBIT T-CELLACTIVATION FOLLOWING LOW-AVIDITY AND ADHESION-INDEPENDENT INTERACTIONS
Authors: GOROCHOV G GROSS G WAKS T ESHHAR Z
Citation: G. Gorochov et al., ANTILEUKOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 ANTIBODIES INHIBIT T-CELLACTIVATION FOLLOWING LOW-AVIDITY AND ADHESION-INDEPENDENT INTERACTIONS, Immunology, 79(4), 1993, pp. 548-555
Risultati: 1-11 |